Yu Qiang

Yu Qiang

Auto-generated profile, based on publicly available information

Yu Qiang

Center for Single-Cell Omics, School of Public Health, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in CARTILAGE
Verified
Journal Article
Open access
YQYu Qiang
Yu Qiang
CZChen Zheng
Chen Zheng
AMAlexander Y. Maslov
Alexander Y. Maslov
ZLZhenzhen Lu
Zhenzhen Lu
MZMin Zhou
Min Zhou
JVJan Vijg
Jan Vijg
Introduction: Cellular senescence, i.e., a state of permanent cessation of cell division, is a hallmark of aging and has been associated with age-related diseases, most notably osteoarthritis (OA). Here we assessed senescence in chondrocytes, first in vitro after treatment with the mutagens N-ethyl-N-nitrosourea (ENU) or bleomycin, and then in vivo in cartilage samples from OA patients and control subjects. Methods: Cellular senescence in cultured chondrocytes treated with mutagens was assessed by senescence-associated β-galactosidase (SA-β-gal) staining and by evaluating the expression levels of p16 and p21 . Cellular senescence in human hip cartilage chondrocytes from OA patients or non-OA controls was similarly evaluated. Apoptosis in vitro was measured by the Bcl-2 / Bax expression ratio, and in vivo by both TUNEL assay and the Bcl-2 / Bax ratio. Results: In human articular cartilage, senescent cells were found to be significantly elevated in OA lesions of patients as compared with normal cartilage of non-OA control subjects. In vitro , senescence was observed in bleomycin-treated chondrocytes, but not in ENU-treated cells. Conclusions: Our findings demonstrate that cellular senescence is associated with the pathogenesis of OA, with DNA damage and mutations as potential contributing factors in OA-associated senescence.